Ng IO - Search Results

Year	Number of Results
1988	1
1989	4
1990	4
1991	3
1992	4
1993	9
1994	5
1995	7
1996	5
1997	7
1998	13
1999	8
2000	15
2001	14
2002	16
2003	24
2004	26
2005	17
2006	11
2007	11
2008	9
2009	17
2010	16
2011	25
2012	22
2013	15
2014	14
2015	17
2016	18
2017	18
2018	9
2019	15
2020	15
2021	20
2022	19
2023	17
2024	14
2025	13

1

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.

Ho DW, Tsui YM, Chan LK, Sze KM, Zhang X, Cheu JW, Chiu YT, Lee JM, Chan AC, Cheung ET, Yau DT, Chia NH, Lo IL, Sham PC, Cheung TT, Wong CC, Ng IO. Ho DW, et al. Among authors: ng io. Nat Commun. 2021 Jun 17;12(1):3684. doi: 10.1038/s41467-021-24010-1. Nat Commun. 2021. PMID: 34140495 Free PMC article.

2

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.

Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, Schwartz ME, Finn RS, Seong J, Wang XW, Paradis V, Abou-Alfa GK, Rimassa L, Kao JH, Zhang BH, Llovet JM, Bruix J, Yip TC, Wong VW, Wong GL, Chan LL, Liu MQ, Gao Q, Shen F, Kelley RK, Cheng AL, Kurosaki M, Toyoda H, Chen WX, Murakami T, Liang P, Zucman-Rossi J, Minami Y, Miyayama S, Wang K, Man K, Hasegawa K, Li Q, Tsuchiya K, Xu L, Chew V, Chow P, Hoshida Y, Lujambio A, Ng IO, Sakamoto M, Park YN, Yau T, Kudo M, Fan J, Zhou J. Chan SL, et al. Among authors: ng io. Lancet. 2025 Aug 16;406(10504):731-778. doi: 10.1016/S0140-6736(25)01042-6. Epub 2025 Jul 28. Lancet. 2025. PMID: 40744051 Review. No abstract available.

3

Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.

Blanc V, Riordan JD, Soleymanjahi S, Nadeau JH, Nalbantoglu I, Xie Y, Molitor EA, Madison BB, Brunt EM, Mills JC, Rubin DC, Ng IO, Ha Y, Roberts LR, Davidson NO. Blanc V, et al. Among authors: ng io. J Clin Invest. 2021 Jan 4;131(1):e138699. doi: 10.1172/JCI138699. J Clin Invest. 2021. PMID: 33445170 Free PMC article.

4

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC.

Wei L, Lee D, Law CT, Zhang MS, Shen J, Chin DW, Zhang A, Tsang FH, Wong CL, Ng IO, Wong CC, Wong CM. Wei L, et al. Among authors: ng io. Nat Commun. 2019 Oct 15;10(1):4681. doi: 10.1038/s41467-019-12606-7. Nat Commun. 2019. PMID: 31615983 Free PMC article.

5

Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.

Zhang Q, Tsui YM, Zhang VX, Lu AJ, Lee JM, Lee E, Cheung GC, Li PM, Cheung ET, Chia NH, Lo IL, Chan AC, Cheung TT, Ng IO, Ho DW. Zhang Q, et al. Among authors: ng io. Theranostics. 2024 Jan 1;14(2):892-910. doi: 10.7150/thno.87962. eCollection 2024. Theranostics. 2024. PMID: 38169544 Free PMC article.

6

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.

Cheu JW, Lee D, Li Q, Goh CC, Bao MH, Yuen VW, Zhang MS, Yang C, Chan CY, Tse AP, Sit GF, Liu CX, Ng IO, Wong CM, Wong CC. Cheu JW, et al. Among authors: ng io. Cell Mol Gastroenterol Hepatol. 2023;16(1):133-159. doi: 10.1016/j.jcmgh.2023.03.001. Epub 2023 Mar 7. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36893885 Free PMC article.

7

Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.

Mok EHK, Leung CON, Zhou L, Lei MML, Leung HW, Tong M, Wong TL, Lau EYT, Ng IOL, Ding J, Yun JP, Yu J, Zhu HL, Lin CH, Lindholm D, Leung KS, Cybulski JD, Baker DM, Ma S, Lee TKW. Mok EHK, et al. Among authors: ng iol. Cancer Res. 2022 Sep 2;82(17):3102-3115. doi: 10.1158/0008-5472.CAN-21-2934. Cancer Res. 2022. PMID: 35767704

8

Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma.

Chen A, Zhang VX, Zhang Q, Sze KM, Tian L, Huang H, Wang X, Lee E, Lu J, Lyu X, Lee MJ, Wong CM, Ho DW, Ng IO. Chen A, et al. Among authors: ng io. Gut. 2024 Dec 10;74(1):90-102. doi: 10.1136/gutjnl-2024-331903. Gut. 2024. PMID: 38839271 Free PMC article.

9

S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos.

Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO. Wang X, et al. Among authors: ng io. Gut. 2023 Jul;72(7):1370-1384. doi: 10.1136/gutjnl-2022-327998. Epub 2023 Jan 11. Gut. 2023. PMID: 36631249 Free PMC article.

10

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK. Leung HW, et al. Among authors: ng iol. Cancer Res. 2021 Jun 15;81(12):3229-3240. doi: 10.1158/0008-5472.CAN-21-0184. Epub 2021 Apr 26. Cancer Res. 2021. PMID: 33903122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

452 results

Results by year